P110α inhibitor alpelisib exhibits a synergistic effect with pyrotinib and reverses pyrotinib resistant in HER2+ breast cancer
Human epidermal growth factor receptor 2 (HER2) plays a critical role in breast cancer progression in patients with HER2 overexpression, thereby driving the development of targeted drugs and advancing therapy strategies targeting this gene. Pyrotinib is a novel irreversible pan-ErbB kinase inhibitor...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2023-09-01
|
| Serie: | Neoplasia: An International Journal for Oncology Research |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S1476558623000386 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|